Author:
Liu Victor P.,Li Wai-Ming,Lofroth Jack,Zeb Mehreen,Patrick Brian O.,Bott Tina M.,Lee Chow H.
Abstract
AbstractDispiropiperazine compounds are a class of molecules known to confer biological activity, but those that have been studied as cell cycle regulators are few in number. Here, we report the characterization and synthesis of two dispiropiperazine derivatives: the previously synthesized spiro[2′,3]-bis(acenaphthene-1′-one)perhydrodipyrrolo-[1,2-a:1,2-d]-pyrazine (SPOPP-3, 1), and its previously undescribed isomer, spiro[2′,5′]-bis(acenaphthene-1′-one)perhydrodipyrrolo-[1,2-a:1,2-d]-pyrazine (SPOPP-5, 2). SPOPP-3 (1), but not SPOPP-5 (2), was shown to have anti-proliferative activity against a panel of 18 human cancer cell lines with IC50 values ranging from 0.63 to 13 µM. Flow cytometry analysis revealed that SPOPP-3 (1) was able to arrest cell cycle at the G2/M phase in SW480 human cancer cells. Western blot analysis further confirmed the cell cycle arrest is in the M phase. In addition, SPOPP-3 (1) was shown to induce apoptosis, necrosis, and DNA damage as well as disrupt mitotic spindle positioning in SW480 cells. These results warrant further investigation of SPOPP-3 (1) as a novel anti-cancer agent, particularly for its potential ability to sensitize cancer cells for radiation-induced cell death, enhance cancer immunotherapy, overcome apoptosis-related drug resistance and for possible use in synthetic lethality cancer treatments.
Funder
Natural Sciences and Engineering Research Council of Canada
Canada Foundation for Innovation
British Columbia Knowledge Development Fund
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Visconti, R., Monica, R. D. & Grieco, D. Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword. J. Exp. Clin. Cancer Res. 35, 153 (2016).
2. Dillon, M. T., Good, J. S. & Harrington, K. J. Selective targeting of the G2/M cell cycle checkpoint to improve the therapeutic index of radiotherapy. Clin. Oncol. 26, 257–265 (2014).
3. Wang, Y. et al. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in P53-mutant colorectal cancer cells. Int. J. Oncol. 53, 1667–1680 (2018).
4. Barnaba, N. & LaRocque, J. R. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma. Cell Cycle 20, 1041–1051 (2021).
5. Nikolakopoulou, A. et al. G2/M checkpoint abrogation with selective inhibitors results in increased chromatid breaks and radiosensitization of 82–6 hTERT and RPE human cells. Front. Pub. Health 9, 675095 (2021).